文献速递临床试验与 GCP流行病学与生物统计

地中海饮食与低脂饮食对心血管疾病长期二级预防(CORDIOPREV):一项随机对照试验

Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial.
PubMed 文献 · Lancet · 2022-05-04

CORDIOPREV 研究在西班牙科尔多瓦单中心纳入 1002 例确诊冠心病患者,随机分配至地中海饮食或低脂饮食组,随访 7 年。主要终点为重大心血管事件复合终点;地中海饮食组主要终点粗发生率 28.1/1000 人年 vs 低脂组 37.7/1000 人年(log-rank P=0.039),多变量校正 HR 为 0.719–0.753;男性获益更明显。

要点

  • 地中海饮食组主要终点粗发生率 28.1/1000 人年,低脂组 37.7/1000 人年(log-rank P=0.039)。
  • 多变量校正 HR 为 0.719(95%CI 0.541-0.957)至 0.753(0.568-0.998),支持地中海饮食。
  • 男性主要终点 67/414(16.2%)vs 94/413(22.8%),多变量校正 HR 0.669(0.489-0.915);女性两组无差异。

核心结论

  • 在二级预防中,地中海饮食在预防重大心血管事件方面优于低脂饮食;结果支持在地中海饮食用于二级预防。

研究设计与样本

  • CORDIOPREV 为单中心随机临床试验,在西班牙科尔多瓦 Reina Sofia 大学医院开展。
  • 纳入 20–75 岁确诊冠心病患者,按 1:1 随机分配至地中海饮食或低脂饮食干预,随访 7 年。
  • 临床研究者(医师、研究者及临床终点委员会成员)对治疗分配设盲,参与者未设盲;由营养师团队实施饮食干预。
  • 主要终点按意向治疗分析,为重大心血管事件复合终点,包括心肌梗死、血运重建、缺血性卒中、外周动脉疾病及心血管死亡。
  • 2009年10月1日至2012年2月28日共纳入 1002 例患者,低脂饮食组 500 例(49.9%),地中海饮食组 502 例(50.1%);平均年龄 59.5 岁(SD 8.7),男性 827/1002(82.5%)。

主要发现

  • 主要终点共 198 例发生:地中海饮食组 87 例,低脂组 111 例;粗发生率 28.1/1000 人年(95%CI 27.9-28.3)vs 37.7/1000 人年(37.5-37.9),log-rank P=0.039。
  • 不同模型的多变量校正 HR 范围为 0.719(95%CI 0.541-0.957)至 0.753(0.568-0.998),支持地中海饮食。
  • 男性中主要终点发生 67/414(16.2%)vs 94/413(22.8%),多变量校正 HR 0.669(95%CI 0.489-0.915),log-rank P=0.013;175 例女性中两组无差异。

临床怎么用

  • 作者认为结果与临床实践相关,支持在地中海饮食用于二级预防。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mediterranean and low-fat diets are effective in the primary prevention of cardiovascular disease. We did a long-term randomised trial to compare the effects of these two diets in secondary prevention of cardiovascular disease. METHODS: The CORDIOPREV study was a single-centre, randomised clinical trial done at the Reina Sofia University Hospital in Córdoba, Spain. Patients with established coronary heart disease (aged 20-75 years) were randomly assigned in a 1:1 ratio by the Andalusian School of Public Health to receive a Mediterranean diet or a low-fat diet intervention, with a follow-up of 7 years. Clinical investigators (physicians, investigators, and clinical endpoint committee members) were masked to treatment assignment; participants were not. A team of dietitians did the dietary interventions. The primary outcome (assessed by intention to treat) was a composite of major cardiovascular events, including myocardial infarction, revascularisation, ischaemic stroke, peripheral artery disease, and cardiovascular death. This study is registered with ClinicalTrials.gov, NCT00924937. FINDINGS: From Oct 1, 2009, to Feb 28, 2012, a total of 1002 patients were enrolled, 500 (49·9%) in the low-fat diet group and 502 (50·1%) in the Mediterranean diet group. The mean age was 59·5 years (SD 8·7) and 827 (82·5%) of 1002 patients were men. The primary endpoint occurred in 198 participants: 87 in the Mediterranean diet group and 111 in the low-fat group (crude rate per 1000 person-years: 28·1 [95% CI 27·9-28·3] in the Mediterranean diet group vs 37·7 [37·5-37·9] in the low-fat group, log-rank p=0·039). Multivariable-adjusted hazard ratios (HRs) of the different models ranged from 0·719 (95% CI 0·541-0·957) to 0·753 (0·568-0·998) in favour of the Mediterranean diet. These effects were more evident in men, with primary endpoints occurring in 67 (16·2%) of 414 men in the Mediterranean diet group versus 94 (22·8%) of 413 men in the low-fat diet group (multiadjusted HR 0·669 [95% CI 0·489-0·915], log-rank p=0·013), than in 175 women for whom no difference was found between groups. INTERPRETATION: In secondary prevention, the Mediterranean diet was superior to the low-fat diet in preventing major cardiovascular events. Our results are relevant to clinical practice, supporting the use of the Mediterranean diet in secondary prevention. FUNDING: Fundacion Patrimonio Comunal Olivarero; Fundacion Centro para la Excelencia en Investigacion sobre Aceite de Oliva y Salud; local, regional, and national Spanish Governments; European Union.

来源:Lancet,查看原文。版权归原作者所有。

引用

  1. Delgado-Lista J, Alcala-Diaz JF, Torres-Peña JD, et al. Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial. Lancet. 2022. PMID: 35525255. doi:10.1016/S0140-6736(22)00122-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。